Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein

J Virol. 1992 Feb;66(2):1139-51. doi: 10.1128/JVI.66.2.1139-1151.1992.

Abstract

The significance and location of sequence-specific information in the CAR/RRE, the target sequence for the Rev protein of the human immunodeficiency virus type 1 (HIV-1), have been controversial. We present here a comprehensive experimental and computational approach combining mutational analysis, phylogenetic comparison, and thermodynamic structure calculations with a systematic strategy for distinguishing sequence-specific information from secondary structural information. A target sequence analog was designed to have a secondary structure identical to that of the wild type but a sequence that differs from that of the wild type at every position. This analog was inactive. By exchanging fragments between the wild-type sequence and the inactive analog, we were able to detect an unexpectedly extensive distribution of sequence specificity throughout the CAR/RRE. The analysis enabled us to identify a critically important sequence-specific region, region IIb in the Rev-binding domain, strongly supports a proposed base-pairing interaction in this location, and places forceful constraints on mechanisms of Rev action. The generalized approach presented can be applied to other systems.

Publication types

  • Comparative Study

MeSH terms

  • Base Sequence
  • Gene Products, rev / genetics*
  • Genes, gag
  • Genes, rev*
  • HIV Long Terminal Repeat
  • HIV-1 / genetics*
  • HIV-1 / physiology
  • Models, Genetic
  • Models, Structural
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Nucleic Acid Conformation
  • Phylogeny
  • Plasmids
  • Polymerase Chain Reaction
  • Protein Conformation
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • Virus Replication / genetics
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, rev
  • RNA, Viral
  • rev Gene Products, Human Immunodeficiency Virus